
BDPARP contains Olaparib 150 mg, a targeted therapy used to treat certain types of ovarian, breast, pancreatic, and prostate cancers. It works by blocking PARP enzymes to help stop cancer cells from repairing themselves.
| Generic Name | Olaparib |
| Manufacturer | BDR |
| Packing | 28 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.